Profiel
Christian Kjellman worked as a Senior Scientist at BioInvent International AB, Head-Research at Cartela AB, and Assistant Professor at the University of Lund.
He is currently the Chief Operating Officer & Senior Vice President at Hansa Biopharma AB.
Dr. Kjellman holds a graduate degree from the University of Lund and a doctorate degree conferred in 1999.
Eerdere bekende functies van Christian Kjellman
| Bedrijven | Functie | Einde |
|---|---|---|
| HANSA BIOPHARMA AB | Chief Operating Officer | 01-02-2023 |
| BIOINVENT INTERNATIONAL AB | Corporate Officer/Principal | - |
| University of Lund | Corporate Officer/Principal | - |
Cartela AB
 Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Chief Tech/Sci/R&D Officer | - |
Opleiding van Christian Kjellman
| University of Lund | Graduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 2 |
|---|---|
| BIOINVENT INTERNATIONAL AB | Health Technology |
| HANSA BIOPHARMA AB | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Cartela AB
Cartela AB Pharmaceuticals: MajorHealth Technology Cartela AB develops therapies for arthritic diseases. It products are mainly used by osteoarthritis and rheumatoid arthritis. Its business is based on the cell surface molecules, integrants a10ß1 and a11ß1. The company was founded by Evy Lundgren-Åkerlund and Donald Gullberg in 2000 and is headquartered in Lund, Sweden. | Health Technology |
